EZH2 and juvenile myelomonocytic leukemia: In contrast to previous reports that emphasized the rarity of genetic mutations in epigenetic modifier genes in JMML [8, 19, 22], we identified components of PRC2, including EZH2 and ASXL1, were mutated at diagnosis (9/93, 9.68%).